Up-regulation of Axin2 by dexamethasone promotes adipocyte differentiation in ROB-C26 mesenchymal progenitor cells

[1]  Y. Mikami,et al.  Inhibition of Wnt/β-catenin signaling by dexamethasone promotes adipocyte differentiation in mesenchymal progenitor cells, ROB-C26 , 2012, Histochemistry and Cell Biology.

[2]  Dong-Eun Kim,et al.  Small molecule-based disruption of the Axin/β-catenin protein complex regulates mesenchymal stem cell differentiation , 2011, Cell Research.

[3]  J. Puzas,et al.  Axin2 controls bone remodeling through the β-catenin–BMP signaling pathway in adult mice , 2009, Journal of Cell Science.

[4]  M. Ohmura,et al.  Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes. , 2009, Life sciences.

[5]  S. Yano,et al.  BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis. , 2009, Biochemical and biophysical research communications.

[6]  Antonio Vidal-Puig,et al.  Adipogenesis and WNT signalling , 2009, Trends in Endocrinology & Metabolism.

[7]  R. Schüle,et al.  FHL2 mediates dexamethasone‐induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β‐catenin signaling‐dependent Runx2 expression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Gongshe Yang,et al.  Roles of Wnt/β-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells , 2008, Molecular and Cellular Endocrinology.

[9]  Feng-Sheng Wang,et al.  Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. , 2008, Endocrinology.

[10]  Nicole A. Ducharme,et al.  Lipid droplets in lipogenesis and lipolysis. , 2008, Endocrinology.

[11]  J. Bilezikian,et al.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.

[12]  I. Gérin,et al.  Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein α and Peroxisome Proliferator-activated Receptor γ* , 2007, Journal of Biological Chemistry.

[13]  M. Hirata,et al.  Differentiation‐Inducing Factor‐1 Alters Canonical Wnt Signaling and Suppresses Alkaline Phosphatase Expression in Osteoblast‐Like Cell Lines , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  F. Costantini,et al.  Mouse Axin and Axin2/Conductin Proteins Are Functionally Equivalent In Vivo , 2005, Molecular and Cellular Biology.

[15]  W. Birchmeier,et al.  The role of Axin2 in calvarial morphogenesis and craniosynostosis , 2005, Development.

[16]  B. Frenkel,et al.  Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3β-dependent and -independent Manner* , 2005, Journal of Biological Chemistry.

[17]  W. Lamers,et al.  Mechanisms of glucocorticoid signalling. , 2004, Biochimica et biophysica acta.

[18]  H. Taniguchi,et al.  Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. , 2004, Biochemical and biophysical research communications.

[19]  Roland Baron,et al.  BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  Wei Hsu,et al.  The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.

[21]  Gwo‐Jaw Wang,et al.  Steroid-Induced Adipogenesis in a Pluripotential Cell Line from Bone Marrow* , 1997, The Journal of bone and joint surgery. American volume.

[22]  T. Vasicek,et al.  Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. , 1995, Genetics.

[23]  G. Stein,et al.  Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes , 1992, Journal of cellular biochemistry.

[24]  A. Yamaguchi,et al.  Clonal osteogenic cell lines express myogenic and adipocytic developmental potential , 1991, Calcified Tissue International.

[25]  C. Devlin,et al.  Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures , 1991, Journal of cellular physiology.

[26]  J. Aubin,et al.  Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. , 1987, Endocrinology.

[27]  Xi He,et al.  Wnt/ β -catenin signaling: components, mechanisms, and diseases , 2010 .

[28]  N. Suzuki,et al.  Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. , 2007, Bone.

[29]  D. Lie,et al.  Wnt signaling and neural stem cells: caught in the Wnt web , 2007, Cell and Tissue Research.

[30]  D. Jarocha,et al.  Mesenchymal stem cells: characteristics and clinical applications. , 2006, Folia histochemica et cytobiologica.